Association of biofilm formation with antimicrobial resistance among the Acinetobacter species in a tertiary care hospital in Bangladesh

Journal of Medicine (Bangladesh)

Volumn 14, Issue 1, 2013, Pages 28-32

  Nahar, Azizun ^a   Anwar, Shaheda ^a   Miah, Md Ruhul Amin ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

Acinetobacter; Biofilm; Multidrug resistance

Indexed keywords

AMIKACIN; AMOXICILLIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; NETILMICIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BANGLADESH; BIOFILM; BLOOD SAMPLING; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; HORIZONTAL GENE TRANSFER; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; OPTICAL DENSITY; SPUTUM SMEAR; TERTIARY HEALTH CARE; THROAT CULTURE; TRACHEAL ASPIRATION PROCEDURE; URINALYSIS;

EID: 84876495931     PISSN: 19979797     EISSN: 20755384     Source Type: Journal    
DOI: 10.3329/jom.v14i1.14533     Document Type: Article

References (20)

1. Jeong SH, Bae IK, Park KO, An YJ, Sohn SG, Jang SJ, et al. Outbreaks of imipenem- resistant Acionetobacter baumannii producing carbapenemases in Korea. J Microbiol 2006; 44: 423-431.
2. Josh SG, Litake GM, Satpute MG, Clinical and demographic features of infection caused by Acinetobacter species. Indian J Med Sci 2006; 60: 351-360.
3. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: Multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-951.
4. Prashanth K, Badrinath S. Epidemiological investigation of nosocomial Acinetobacter infections using AP- PCR and Pulse field gel electrophoresis. Indian J Med Res 2005; 122:408-418.
5. Jain R, Danziger LH. Multidrug- resistant Acinetobacter infections: An emerging challenge to clinicians. Ann Pharmacother 2004; 38: 1449-1459.
6. Joly-Guillou ML. Clinical Impact and Pathogenicity Of Acinetobacter. Clinical Microbiology and Infection 2005;11: 868-873.
7. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol1 SY, Cho DT and Kim J. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbial Infect 2008; 14:49-54.
8. Forbes BA, Sham DF, Weissfeld AS. Bailey and Scott's diagnostic Microbiology, 10th Edition. Mosby, New York 1998: 167-187.
9. Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. Mackie and McCartney Practical Medical Microbiology, EDs: Collee, Marmion, Fraser, Simmons, 14th Edition. Churchill Livingstone, NY, 1996: 131-149.
10. Bauer AW, Kirby WMM, Sherris JC, Turek M. Antibiotic sensitivity testing by a standardized single disk method. American Journal of Clinical Pathology 1966; 45:493-496.
11. National Committee for Clinical Laboratory Standards. (2001) Performance standards for Antimicrobial Susceptibility Tests. Eleventh informational supplement. NCCLS document M100-S11 NCCLS. Wayne, Pennsylvania, USA.
12. Toledo-Arana A, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M, Amorena B, Leiva J, Penades JR and Lasa I. The Enterococcal Surface Protein, ESP, Is Involved in Enterococcus faecalis Biofilm Formation. Applied and Environmental Microbiology 2001; 67(10): 4538-4545.
13. Stepanovic S, Vukovic D, Hola V, Bonaventura G D, Djukic S, Cirkovic I, Ruzicka F. Quantification of Biofilm in microtitre plates: overview for assessment of biofilm production by staphylococci. APMIS 2007; 115:891-899.
14. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common Cause of Persistent Infections. Science 1999; 284:1318-1322.
15. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001;45:999-1007.
16. Dheepa M, Vinitha L, Appalaraju B. Comparision of biofilm production and multiple drug resistance in clinical isolates of Acinetobacter baumannii from a tertiary care hospital in South India. Int J Pharm Biomed Sci 2011; 2(4), 103-107.
17. Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros M, Pachon J, Pascual A, Martinez-Martinez, McQueary, Actis L, Vila J and the Spanish Group for the Study of Nosocomial Infections. Biofilm formation Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008; 14:276-278.
18. Cevahir N, Demir M, Kaleli I, Gurbuz M, Tikvesli S. Evaluation of Biofilm production, gelatinase activity and mannose- resistant hemagglutination in Acinetobacter baumannii strains. J of Microbiology, Immunology and Infection 2008; 41:513-518.
19. Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandra S, Prashanth K. Correlation Between Biofilm Production and Multiple Drug Resistance In Imipenum Resistant Clinical Isolates of Acinetobacter baumannii. Indian J of Medical Microbiology 2008; 26(4): 333-7.
20. Vijaya BS, Govindan R, Preeti P, Kurt S, Daniel T, Prapas P, Mario M, Wondwossen AG. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann Clin Microbial Antimicrob 2009, 8, 21.